| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |